Financial Performance Overview Moderna reported Q4 2024 revenue of $966 million, marking a 66% decline year-over-year (...
Moderna has officially launched its new vaccine manufacturing facility at Monash University’s Clayton campus in so...
Moderna, Inc. and Cenra Healthcare, the sales and marketing arm of Cenra Inc., have entered into a joint agreement regar...
Moderna, Inc. has announced that the Taiwan Food & Drug Administration (FDA) has approved an updated formulation of ...
From January to June 2024, Moderna solidified its position as a leader in biotechnology, making substantial progress acr...
Moderna, Inc. and Mitsubishi Tanabe Pharma Corporation have entered into a joint agreement regarding the co-promot...
US-based biotech firm Moderna, Inc. has announced the launch of the mRNA Platform Incubator Network, a pioneering initia...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and American firm Moderna, Inc. have entered into ...
Australia's Monash University and American firm Moderna have announced the establishment of the Monash-Moderna Quantitat...
American biotech firm Moderna has announced plans to establish an Enterprise Solutions Hub in the Philippines. The Moder...
